The Respiri Board announced the appointment of Brian Leedman as Non-executive Director. Brian is a healthcare company entrepreneur and experienced company director having co-founded six healthcare/biotechnology companies on the ASX including Oncosil Medical, Biolife Sciences (acquired by Imugene Limited in 2014) and ResApp Health (acquired by Pfizer in September 2022). He is the former director of Alcidion Limited and Chairman of Neurotech International, Nutritional Growth Solutions, NeuroScientific Biopharmaceuticals, Ausbiotech (WA) and holds a Bachelor of Economics and a Master of Business Administration from The University of Western Australia.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.037 AUD | +8.82% | +19.35% | +23.33% |
09/05 | Transcript : Respiri Limited - Special Call | |
30/04 | Respiri to Raise AU$1.6 Million via Placement | MT |
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+23.33% | 26.21M | |
+12.15% | 227B | |
+14.90% | 197B | |
+18.22% | 141B | |
+29.15% | 110B | |
+0.53% | 64.15B | |
+16.92% | 53.72B | |
+6.33% | 51.75B | |
+10.93% | 45.2B | |
+5.87% | 37.37B |
- Stock Market
- Equities
- RSH Stock
- News Respiri Limited
- Respiri Limited Appoints Brian Leedman as Non-Executive Director